The European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) conducted a survey on the status of PET/SPECT/CT multimodality imaging practices in Europe--the results of which are published in the January issue of European Journal of Nuclear Medicine and Molecular Imaging.
“The majority of the members of both societies believe that the proportion of PET/CT conducted as a full diagnostic CT with contrast enhancement will increase over time,” said the report's first author Alberto Cuocolo, MD, from the department of biomorphological and functional sciences, University of Naples Federico II, Italy.
However, the results of the survey showed that there was wide heterogeneity in the current practice of multimodality imaging in Europe, which may limit its full potential and integration.
The survey also found 18F-FDG was the most commonly used PET tracer for clinical applications.
“The large majority of respondents were in favor of an interdisciplinary training program being developed on a European level together by the EANM and the ESR and the respective sections of the European Union of Medical Specialists,” said Cuocolo.